Search
for
Sort by
Research 391–420 of 1000+
- Causal effects of glutamine and lipid-related metabolites on alopecia areata: A 2-sample Mendelian randomization study
- Causal Effects of Lipids-Related Metabolites on Androgenic Alopecia: A Mendelian Randomization Study
- Lipid profile in androgenetic alopecia
- Lab Quality Management and Methodology
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Factors associated with premature hair graying in a young Indian population
- Is early onset androgenetic alopecia related to hyperuricemia? A case control study
- A Comprehensive Review of Acne Vulgaris
- Inhibition of 5-Alpha Reductase Attenuates Cardiac Oxidative Damage in Obese and Aging Male Rats via the Enhancement of Antioxidants and the p53 Protein Suppression
- Sex hormones and acne
- Hormone therapy in acne
- Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: A cross-sectional study clinical study
- Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome
- Role of Oxidative Stress in Obese and Nonobese PCOS Patients
- Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome
- Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS)
- Targeting IGF1‐Induced Cellular Senescence to Rejuvenate Hair Follicle Aging
- Possible intermediary role of ghrelin in seborrhea
- Prevalence of polycystic ovary syndrome in unselected women from southern China
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Increased Prevalence of Insulin Resistance and Metabolic Syndrome in Men With Early‐Onset Androgenetic Alopecia: A Case–Control Study
- Management of “hyperandrogenism” confounded by dermatology biotin prescriptions
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Prenatal Androgenization of Ewes as a Model of Hirsutism in Polycystic Ovary Syndrome
- Clinical and Biochemical Characteristics in PCOS Women With Menstrual Abnormalities.
- Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome.
- Further Clinical Evidence for the Effect of IGF-1 on Hair Growth and Alopecia
- Serum anti-Müllerian hormone: A potential biomarker for polycystic ovary syndrome
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders